Journal of Oncology Translational Research

Libo Zhang

Publications

• Review Article
  Advances in ALK Targeted Therapy for Neuroblastoma
  Author(s): Libo Zhang and Sylvain BaruchelLibo Zhang and Sylvain Baruchel
  
  Significant advances have been made to understand the association between ALK genetic aberrations and disease prognosis in neuroblastoma. ALK targeted therapies are evolving quickly and several randomized controlled trials of ALK inhibitors are underway or nearing completion in adult cancers. Ongoing research will bring new challenges and newer technologies to fully define the pathogenic and prognostic alterations, to stratify the risk of recurrence or progression, and to develop optimal monitoring and treatment strategies in this malignancy... Read More»
  DOI: 10.4172/2476-2261.1000114

  Abstract PDF